Your event should be here ! To publish, manage, promote... To learn or to be formed ... Online registrations

Site language : English - Français
Ref : 26274
Event :Asthma And COPD

Dates :Wednesday April 11th, 2018 - Thursday April 12th, 2018

Location :Copthorne Tara Hotel
Scarsdale Place, Kensington
W8 5SY London, United Kingdom

Type :Conference & Seminar - International audience

Accreditation :--


 

Further information

 

 

Recent advances in injectable biologics and smart medical devices as led to an increase in novel approaches to treating severe asthma and COPD as well as the regulations to take into consideration. As technology soars, the need for guideline updates from regulators has increased and continues to be modified.
 
With asthma and chronic obstructive pulmonary disorder (COPD) affecting about 500 million people worldwide, opportunities in drug development are vast and reducing serious attacks by improving adherence could save $19 billion a year in U.S. healthcare costs.
 
Join us as we discuss current clinical trials and the innovative digital technology being used to improve clinical adherence. Leading industry experts will be looking at the use of 'real world data' human factors in the design of medical devices and triple combination treatments on the market. We will also be looking at asthma and COPD Phenotyping and biomarker application and differences between in the EU and US for the approval of biologics. We will be exploring the complexities of dry powder formulation and helping you determine clinical efficacy and endpoints.
 
Topics of Discussion for 2018
- Early detection and prevention of COPD and Asthma
- The use of triple combination therapies
- Health economics and market access for innovative treatments
- Regulatory updates in bioequivalence and drug-device combinations
- Enhancing dry powder formulation
- Asthma and COPD Phenotyping and biomarker application for personalised medicines
 
Featured Speakers:
 
- Wisia Wedzicha, Professor of Respiratory Medicine and Head of Respiratory Clinical Science, Imperial College London
- Quan Yang, Senior Pharmaceutical Assessor, MHRA
- Maria Gerhardsson de Verdier, Director of Epidemiology, AstraZeneca
- Rene van der Merwe, Senior Director Respiratory And Inflammation, MedImmune
- Alison Moore, Clinical Development Director, GSK 
- Peter Barnes, Head of Respiratory Medicine, Imperial College London
 
URLs:
 
Prices: 
Book by 15th December and save £400: GBP 1099
Book by 31st January and save £200: GBP 1299
Book by 28th February and save £100: GBP 1399
Standard: GBP 1499
 
Time: 8:30 am to 5:30 pm
 
Speakers: Allergy Therapeutics, Amgen, AstraZeneca, Boehringer Ingelheim, Cambridge Consultants Ltd, GSK, Imperial College London, Janssen, Kings College London, MedImmune, MHRA, National Heart And Lung Institute, National University Health System, Singapore, NIHR Biomedical Research Centre, University of Edinburgh Medical School

Location

Map and directions
Conference address :
Copthorne Tara Hotel
Scarsdale Place, Kensington
W8 5SY London
United Kingdom
Map and directions

Further information

To access the information you need to be connected. Creating an account is easy and free!

Log to your account
Register on Doctorama

Details

Asthma And COPD Internal medicine
asthma, copd, inhalation, anti-body, exacerbation, biomarkers, respiratory, inhalers
Everyone
-- -- --
English

Other

For more information on Asthma And COPD, plsase contactr SMi Group

To obtain a letter of invitation, you must be logged

Log to my account
Register on Doctorama


Recommend this event